全文获取类型
收费全文 | 16422篇 |
免费 | 2262篇 |
国内免费 | 266篇 |
专业分类
耳鼻咽喉 | 260篇 |
儿科学 | 230篇 |
妇产科学 | 196篇 |
基础医学 | 556篇 |
口腔科学 | 186篇 |
临床医学 | 731篇 |
内科学 | 717篇 |
皮肤病学 | 109篇 |
神经病学 | 162篇 |
特种医学 | 762篇 |
外国民族医学 | 45篇 |
外科学 | 1676篇 |
综合类 | 1851篇 |
预防医学 | 619篇 |
眼科学 | 125篇 |
药学 | 511篇 |
7篇 | |
中国医学 | 175篇 |
肿瘤学 | 10032篇 |
出版年
2024年 | 34篇 |
2023年 | 262篇 |
2022年 | 561篇 |
2021年 | 753篇 |
2020年 | 700篇 |
2019年 | 683篇 |
2018年 | 628篇 |
2017年 | 685篇 |
2016年 | 760篇 |
2015年 | 733篇 |
2014年 | 1131篇 |
2013年 | 1129篇 |
2012年 | 1056篇 |
2011年 | 1122篇 |
2010年 | 1020篇 |
2009年 | 932篇 |
2008年 | 784篇 |
2007年 | 932篇 |
2006年 | 840篇 |
2005年 | 689篇 |
2004年 | 570篇 |
2003年 | 488篇 |
2002年 | 398篇 |
2001年 | 359篇 |
2000年 | 285篇 |
1999年 | 247篇 |
1998年 | 209篇 |
1997年 | 164篇 |
1996年 | 128篇 |
1995年 | 94篇 |
1994年 | 66篇 |
1993年 | 49篇 |
1992年 | 60篇 |
1991年 | 43篇 |
1990年 | 31篇 |
1989年 | 31篇 |
1988年 | 44篇 |
1987年 | 28篇 |
1986年 | 17篇 |
1985年 | 46篇 |
1984年 | 27篇 |
1983年 | 27篇 |
1982年 | 26篇 |
1981年 | 17篇 |
1980年 | 18篇 |
1979年 | 12篇 |
1978年 | 9篇 |
1977年 | 14篇 |
1976年 | 4篇 |
1975年 | 3篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
101.
Clark J Li W Smith G Shannon K Clifford A McNeil E Gao K Jackson M Mo Tin M O'Brien C 《Head & neck》2005,27(2):87-94
BACKGROUND: Patients with advanced cervical metastases from mucosal squamous cell carcinoma have a poor prognosis because of their high risk of regional and distal failure. This study aims to evaluate the outcomes of patients with clinical N2 or N3 disease managed with surgery and postoperative radiotherapy. METHODS: From a comprehensive computerized database, 181 entered patients who had neck dissection for N2 or N3 disease between 1988 and 1999 were evaluated. The mean age was 62 years, and minimum follow-up was 3 years. RESULTS: A total of 233 neck dissections were performed in 181 patients, including 163 comprehensive and 70 selective dissections. Postoperative radiotherapy was given in 82% of cases. The local control rate was 75% at 5 years, and control of disease in the treated neck was achieved in 86%. Macroscopic extracapsular spread (ECS) significantly increased regional recurrence (p = .001). Adjuvant radiotherapy significantly improved neck control (p = .004) but did not alter survival. Patients with ECS (both microscopic and macroscopic) who received radiotherapy had a significantly better survival than did patients with ECS who did not receive radiotherapy. Disease-specific survival for the entire group was 39% at 5 years. By use of multivariate analysis, macroscopic ECS and N2c neck disease were independent adverse prognostic factors for survival (p = .001). CONCLUSIONS: Despite a high rate of control in the treated neck, the poor survival (39%) in this patient group indicates that adjuvant therapeutic strategies need to be considered. 相似文献
102.
BACKGROUND: Osteoradionecrosis (ORN) is a nonhealing wound of the bone that is difficult to manage. Is a treatment combining pentoxifylline (PTX) and tocopherol (vitamin E) boosted by clodronate effective in reversing this fibronecrotic process? METHODS: Eighteen consecutive patients previously irradiated for head and neck cancer had exteriorized mandible ORN. Length of exposed bone (L) was 13.4 +/- 8 mm, and the mean subjective objective medical management and analytic evaluation of injury (SOMA) score was 12.6 +/- 4.9. Between June 1995 and January 2002, all 18 were given a daily oral combination of 800 mg of PTX and 1000 IU of vitamin E for 6 to 24 months. In addition, the last eight patients who were the worst cases were given 1600 mg/day clodronate 5 days a week. RESULTS: The treatment was well tolerated. All patients improved at 6 months, with 84% mean L and 67% mean SOMA score reductions. Sixteen (89%) of 18 patients achieved complete recovery, 14 in 5 +/- 2.6 months. The remaining two patients exhibited a 75% response at 6 months. CONCLUSION: PTX-vitamin E boosted by clodronate is an effective treatment of mandibular ORN that induces mucosal and bone healing in a median period of 6 months. 相似文献
103.
Abraham André Arturo Geng-Cahuayme Berta Sáez-Giménez Manuel Altabas-González Miriam Vázquez-Varela Cristina Berastegui-Garcia Jordi Giralt-López de Sagredo Marta Zapata-Ortega Enar Recalde-Vizcay Manuel López-Meseguer 《Clinical transplantation》2023,37(2):e14891
Total lymphoid irradiation (TLI) is an alternative treatment for chronic lung allograft dysfunction (CLAD). However, data regarding its efficacy and tolerance are scarce. This study included patients with CLAD treated with TLI at our center between 2011 and 2018. Clinical characteristics before and after TLI and related complications were analyzed. Forty patients with CLAD (twenty-nine bronchiolitis obliterans syndrome [BOS], nine restrictive allograft syndrome [RAS], and two mixed) were included. Significant attenuation of the forced expiratory volume in 1-sec (FEV1) decline slope was observed in all phenotypes, in both the BOS and RAS. The median FEV1 12, 6, and 3 months pre-TLI were as follows: 1980 (IQR 1720-2560), 1665 (IQR 1300-2340) and 1300 (IQR 1040-1740) ml (p < .001), while the median FEV1 at 3, 6, and 12 months post-TLI was 1110 (IQR 810–1440), 1130 (IQR 860–1470), and 1115 (IQR 865–1490) ml (p = .769). No dropouts due to radiation toxicity were observed. The mean survival according to the Karnofsky Performance Status Scale (KPS) >70 or ≤70 at baseline was 1837 (IQR 259–2522) versus 298 (IQR 128–554) days (p < .0001), respectively. In conclusion, TLI may stop FEV1 decline in both BOS and RAS. Moreover, a good KPS score may be an important prognostic factor. 相似文献
104.
目的探讨放疗剂量对早期鼻腔NK/T细胞淋巴瘤预后的影响。方法将64例早期鼻腔NK/T细胞淋巴瘤患者,根据放疗剂量大小分为〈50Gy组(n=20),51~60Gy组(n=24)和〉60Gy组(n=20),观察比较各组局部控制率和5年生存率。结果经随访〈50Gy组局部控制率68.5%,5年生存率42.1%。51~60Gy组局部控制率达到82.5%,生存率达60.9%。两组对比在局部控制率和5年生存率有统计学意义(P〈0.05),但51—60Gy组和〉60Gy组对比无统计学意义。结论以51—60Gy剂量的放疗能保证良好的局部控制率,提高患者总生存率,建议临床在选择放疗剂量时以51—60Gy为宜。 相似文献
105.
目的 对胸中上段食管癌患者进行静态调强(IMRT)和容积旋转调强(VMAT)两种放疗方式的剂量学对比研究。方法 对20例IMRT治疗的食管癌患者行VMAT(单弧和双弧)计划的重新设计。在单弧的VMAT计划中,对其中5例患者行不同子野间隔(4°、3°、2°)以及不同计划系统(Monaco和MasterPlan)的计划设计。比较靶区和危及器官(OAR)的剂量学差异及治疗参数。结果 双弧VMAT计划各项靶区剂量学参数明显好于IMRT计划和单弧VMAT计划(P<0.05),靶区均匀性(HI)(P<0.05)和适形度(CI)(P<0.05)最好。危及器官参数VMAT可在一定程度上降低OAR的受照剂量,但是IMRT对肺组织和正常组织(E-P)的低剂量保护要优于VMAT(P<0.05);不同子野间隔的VMAT计划中,2°相对于3°和4°其OAR的受照剂量是减小的(P<0.05),除了心脏的Dmean;不同计划系统设计的VMAT计划,以Monaco对OAR的保护为最优(P<0.05);VMAT的机器跳数少于IMRT,而且有效节省了治疗时间。 结论 VMAT方式相对于IMRT能够实现更好的靶区覆盖、均匀性和适形度,同时能降低脊髓、肺组织、心脏和E-P的受照剂量;对于VMAT来说,双弧技术、小子野角度间隔能够进一步地改善靶区和OAR的受照剂量;此外,在物理参数和优化参数一致的前提下,Monaco可以更好地保护OAR。 相似文献
106.
FDG-PET/CT-guided intensity modulated head and neck radiotherapy: a pilot investigation 总被引:7,自引:0,他引:7
Schwartz DL Ford EC Rajendran J Yueh B Coltrera MD Virgin J Anzai Y Haynor D Lewellen B Mattes D Kinahan P Meyer J Phillips M Leblanc M Krohn K Eary J Laramore GE 《Head & neck》2005,27(6):478-487
BACKGROUND: 2-deoxy-2[(18)F]fluoro-D-glucose-positron emission tomography (FDG-PET) imaging can be registered with CT images and can potentially improve neck staging sensitivity and specificity in patients with head and neck squamous cell cancer. The intent of this study was to examine the use of registered FDG-PET/CT imaging to guide head and neck intensity modulated radiotherapy (IMRT) planning. METHODS: Twenty patients with squamous cell carcinoma of the oral cavity, oropharynx, larynx, or hypopharynx underwent FDG-PET and contrast-enhanced CT imaging of the head and neck before neck dissection surgery. Combined FDG-PET/CT images were created by use of a nonrigid image registration algorithm. All IMRT plans were theoretical and were not used for treatment. We prescribed 66 Gy in 30 fractions to FDG-avid CT abnormalities and nodal zones directly involved with disease, without prophylactic coverage of uninvolved neck levels. Matched CT-guided IMRT plans designed according to the specifications of Radiation Therapy Oncology Group (RTOG) H-0022 were available for comparison. We investigated the feasibility of FDG-PET/CT-directed IMRT dose escalation in five patients with FDG-avid disease located away from critical normal structures. After 66 Gy, FDG-avid disease with 0.5-cm margins was boosted in 220 cGy increments until dose-limiting criteria were reached. RESULTS: Elimination of prophylactic coverage to FDG-PET/CT-negative neck levels markedly reduced mean dose (Dmean) to the contralateral parotid gland (p < .001) and Dmean to the laryngeal cartilage (p = .001). No FDG-PET/CT-directed plan missed pathologically verified nodal disease. During the dose escalation exercise, we successfully increased the dose to 95% of the planning target volume (PTV95%) to a mean of 7490 cGy (range, 7153-8098 cGy). CONCLUSIONS: We demonstrate early proof of the principle that FDG-PET/CT-guided IMRT planning can selectively target and intensify treatment of head and neck disease while reducing critical normal tissue doses. Routine clinical use of such planning should not be engaged until the accuracy of FDG-PET/CT is fully validated. Future directions, including refinement of treatment to gross disease and radiologically uninvolved neck nodal levels, are discussed. 相似文献
107.
BACKGROUND: There is an increasing risk of cervical lymph node metastases as tumour thickness increases in patients with anterior tongue squamous cell carcinoma (SCC). The role of elective neck treatment in early anterior tongue cancer in unclear. METHODS: Patients diagnosed with anterior tongue cancer and treated with glossectomy +/- neck dissection were identified. The aim was to document the incidence of pathological lymph node metastases and outcome with increasing tumour thickness. The Cox proportional hazards model was used to identify prognostic factors. Survival curves were calculated using the Kaplan-Meier method. RESULTS: Between 1980 and 2002 99 patients (63 male and 36 female) with anterior tongue SCC were treated at Westmead Hospital, Sydney, and had a documented tumour thickness. Median age at diagnosis was 63 years (23-89 years). Median follow up was 37 months (6-205 months). Sixty-three patients underwent partial glossectomy and neck dissection. Thirty-six underwent partial glossectomy only. At the time of presentation 45/63 (71%) were clinically node negative. Using tumour thickness < or = 5 mm versus > 5 mm the incidence of nodal metastases was 8% versus 51% (P = 0.007). On multivariate analysis pathological nodal involvement and advanced stage both significantly predicted survival. The 2-year disease-free survival difference based on tumour thickness (< or = 5 mm vs > 5 mm) was 76% versus 65% (P = 0.47). CONCLUSIONS: Elective treatment to the ipsilateral neck is not indicated in all patients with anterior tongue cancer. However, for patients with a tumour thickness > 5 mm it is recommended that they undergo treatment to the ipsilateral neck in the form of a supraomohyoid neck dissection. 相似文献
108.
M. Ferri A. Laghi† P. Mingazzini‡ F. Iafrate† L. Meli F. Ricci‡ R. Passariello† V. Ziparo 《Colorectal disease》2005,7(4):387-393
OBJECTIVE: Pre-operative staging of rectal cancer should identify patients with extrarectal spread, who might benefit from pre-operative radiotherapy, and patients with minimal sphincteral involvement, who can avoid permanent colostomy. The aim of this study was to assess the accuracy of Magnetic Resonance Imaging (MRI) to predict tumour stage and sphincter status. PATIENTS AND METHODS: Thirty-three patients with a rectal tumour were pre-operatively assessed by MRI with a phased-array coil. Imaging results were correlated with the final pathological findings. RESULTS: The overall accuracy of pre-operative staging with MRI was 88% (k = 0.75) for extramural tumour invasion and 59% (k = 0.26) for lymph node metastases. MRI correctly evaluated the infiltration of the anal sphincters in 87% of patients (7 of 8 patients with low rectal tumour). CONCLUSION: MRI provides the surgeon with valuable information regarding extramural tumour spread and sphincteral involvement, enabling appropriate selection of patients for pre-operative adjuvant therapy or sphincter-saving surgery. 相似文献
109.
Treatment outcomes of intensity‐modulated radiotherapy versus 3D conformal radiotherapy for patients with maxillary sinus cancer in the postoperative setting 下载免费PDF全文
110.
Toxicity and efficacy of accelerated radiotherapy with concurrent weekly cisplatin for locally advanced head and neck carcinoma 下载免费PDF全文